IRVINE, Calif., May 23, 2007 (PRIME NEWSWIRE) -- "Demand drives the market. This is a well-worn economic concept that propels companies and products into the marketplace as unique and innovative products and services meet the fervor of mass acceptance," stated SmallCap Sentinel analyst D.R. Clark "This is also often the genesis of industry leaders and corporate giants as business plans are molded around a waiting and eager audience."
"Such may be the case with Cryobanks International, which has agreed to be acquired by BioStem Inc., announcing this morning that it is expanding its global marketing push as a result of massive demand for its world-recognized cord blood technology," Clark added. "In addition to the eight facilities presently under contract, the marketing and sales campaign will now encompass over 11 countries with revenue projections exceeding $25M."
BioStem, Inc. (OTCBB:BTEM) is in the process of acquiring Cryobanks International Inc. (CII). CII is a leader in the collection, processing, and banking of stem cells derived from the umbilical cord (CBSCs) immediately after birth. The units of cord blood (CB) are processed and stored at CII for use in unrelated transplants (where the donor is a likely compatible match, but is anonymous and unrelated to the recipient) and for personal storage and use.
An informational report featuring BioStem is available at: http://stockupticks.com/profiles/5-23-07.html
The report will also address issues affecting related companies including Gilead Sciences, Inc. (Nasdaq:GILD), Invitrogen Corporation (Nasdaq:IVGN), and Geron Corporation (Nasdaq:GERN)
Individuals may register to receive free future reports at: http://stockupticks.com/register.html.
To have your company featured in StockUpTicks or SmallCap Sentinel please use the contact information below.
The SmallCap Sentinel logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3664
Statements herein contain forward-looking statements and are subject to significant risks and uncertainties that affecting results. SmallCap Sentinel/StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid five thousand dollars by Blue Wave Advisors on behalf of BTEM and for preparation and distribution of this report and other advertising services over a ninety day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.